Skip to content
HomeOur CompanyIn Front of Cancer: Mary’s Story
Mary Guckert, Vice President, Oncology Delivery Unit, Global Development, Johnson & Johnson sitting at a table being interviewed

In Front of Cancer: Mary’s Story

Each day, we are working toward our ambition to get in front of cancer.

For Mary Guckert, Vice President, Oncology Delivery Unit, Global Development, Johnson & Johnson, this work is deeply personal. Her story, and the stories of patients everywhere, inspire and remind us why we will never settle until the disease is behind everyone.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.